Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
280Bio Provides Update on the KRAS Inhibitor TEB-17231 at the 2023 AACR Annual Meeting 2023-03-21 20:00
Kintor Pharma's KX-826 and GT20029 for Treatment of Androgenetic Alopecia (AGA) and Acne Presented at AAD 2023 2023-03-21 15:22
Two-Component Recombinant COVID-19 Vaccine ReCOV Granted With Emergency Use Authorization In Mongolia 2023-03-21 13:59
BLA Accepted in China for Boan Biotech's Denosumab Injection (BA1102) for the Oncology Indications 2023-03-21 13:46
Innovent Announces Clinical Data of Multiple Trials Will be Presented at the AACR Annual Meeting 2023 2023-03-21 08:00
Sirnaomics to Present Latest Developments in Polypeptide Nanoparticle Platform at the 4th Annual RNAi-Based Therapeutics Summit 2023-03-20 23:27
Transcenta Holding Limited (6628.HK) to Hold 2022 Annual Results Release Conference Call 2023-03-20 21:12
Hovione and Ripple Enter Strategic Partnership to Expand Epidel® Platform into Non-Ophthalmic Space 2023-03-20 21:00
CNEY Wins a Large Activated Carbon Order 2023-03-20 20:30
I-Mab to Report Full Year 2022 Financial Results and Provide Corporate Update on March 31, 2023 2023-03-20 20:00
Guo Guangchang Stresses Healthy Corporate Development and Expresses Full Confidence in the Future 2023-03-20 17:12
ETANA HAS SECURED FINANCING FROM DEG, EAST VENTURES AND OTHER GLOBAL INVESTORS 2023-03-20 15:22
Antengene Announces Five Upcoming Presentations at the 2023 American Association for Cancer Research Annual Meeting 2023-03-20 15:20
Hanmi Pharmaceutical's Combination Drug for Dyslipidemia Treatment, 'Rosuzet': Confirmed Non-inferiority Efficacy and Safety Compared to Monotherapy in 'The Lancet' & 'European Heart Journal' 2023-03-17 21:00
Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion 2023-03-17 19:25
China's first personalized neoantigen-targeted cancer vaccine receives NMPA's clinical trial approval 2023-03-17 14:56
YS BIOPHARMA TO RING THE OPENING BELL AND DEBUT ON NASDAQ 2023-03-17 04:30
Nav1.7 Selective Inhibitor OLP-1002 Shows Strong Efficacy and Long Therapeutic Duration according to Interim Findings from a Phase 2a Study in OA Patients 2023-03-16 21:00
FDA Approves Expanded Indication for Telix's Illuccix® to Include Patient Selection for PSMA-Directed Radioligand Therapy 2023-03-16 20:28
Bolstering Healthcare Quality in Malaysia with Renowned Flagship Hospitals 2023-03-16 16:12
1 80 81 82 83 84 377